“The context and conditions of the pandemic have changed dramatically and favorably” By Jennifer Henderson, business and research writer, MedPage Today. The moment for universal masking in the context of COVID in healthcare “has come and gone,” if only for now, argued infectious disease specialists in […]
Infectious disease experts urge abandoning the universal use of face masks. Read More »
The latest update to the Gesida HIV/HCV coinfection study confirms the downward trend, placing the rate of coinfected patients below 1%. Sonia Moreno, Madrid. The study on the prevalence of HCV coinfection in people with HIV in Spain, conducted by Gesida, the AIDS Study Group of the Spanish Society of Infectious Diseases.
The hepatitis C virus is nearing elimination in people living with HIV. Read More »
Deaths in South Florida Prove Why the BBL Is the “Most Dangerous Cosmetic Procedure Ever Performed” By Sophie Putka, Business & Research Writer, MedPage Today Last updated: April 12, 2023 In surgical circles, the Brazilian butt lift (BBL) is known as the most dangerous cosmetic procedure ever performed.
What makes the Brazilian butt lift so deadly? Read More »
By Dr. Andrew L. Beam, Dr. Jeffrey M. Drazen, Dr. Isaac S. Kohane, and Dr. Tze-Yun Leong. Artificial intelligence (AI) has recently gained public prominence with the publication of deep learning models that can generate anything from art to academic papers with minimal human intervention. This advance has reignited the debate about
Artificial Intelligence in Medicine. Read More »
Concern grows, although no cases have been detected outside Equatorial Guinea and Tanzania so far. By Jennifer Henderson, Business and Research Writer, MedPage Today. Although there have been no confirmed cases of Marburg virus disease (MVD) outside of Equatorial Guinea and Tanzania, doctors and public health experts are concerned.
The CDC is alerting doctors to be on the lookout for possible imported cases of Marburg. Read More »
UNAIDS welcomes the announcement by the Medicines Patent Pool (MPP) and ViiV of three licenses signed with generic manufacturers Aurobindo, Cipla, and Viatris for long-acting cabotegravir for PrEP (pre-exposure prophylaxis). PrEP reduces the risk of HIV infection through sexual or drug use.
Consideration is being given to expanding the criteria and providing pre-exposure prophylaxis to other risk groups to eradicate the virus. By Marisa García. GeSIDA, the AIDS Study Group of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), has presented the updated guidelines on pre-exposure prophylaxis (PrEP) as a tool for HIV prevention.
GeSIDA updates its recommendations guide to facilitate PrEP as an HIV prevention tool Read More »
Héctor Rodríguez, editor and journalist specializing in science and nature: It is well known that wastewater analysis can provide clues about the state of infectious diseases in a community or the consumption of medications, whether prescription or illicit. However, it can also provide information about persistent compounds.
Toilet paper, an unexpected source of contamination Read More »
The International AIDS Society (IAS) is deeply concerned that Uganda’s Parliament has passed anti-gay legislation that is an extreme violation of human rights and threatens to reverse the country’s progress in the HIV response. The legislation was passed on Tuesday, March 21, and
On the occasion of World Tuberculosis Day, the World Health Organization (WHO) announces the extension of the WHO Director-General’s flagship TB initiative for the period 2023-2027, with the aim of accelerating progress towards ending TB and achieving the
WHO supports Director-General's flagship initiative to combat tuberculosis Read More »
